Related Experiment Video

Updated: Jul 16, 2026

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions
05:41

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Characterisation of DEHAL1 expression in thyroid pathologies

Kerstin Krause1, Stefan Karger, Oliver Gimm

  • 1III. Medical Department, University of Leipzig, Ph.-Rosenthal-Str. 27, 04103 Leipzig, Germany.

European Journal of Endocrinology
|February 27, 2007
PubMed

Insights

Iodotyrosine dehalogenase 1 (DEHAL1) is upregulated in toxic thyroid conditions but downregulated in advanced thyroid cancers. DEHAL1 expression levels and localization may indicate thyroid cell differentiation status.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Iodotyrosine dehalogenase 1 (DEHAL1) is a key transmembrane protein in iodide recycling within the human thyroid gland.
  • Understanding DEHAL1's role is crucial for diagnosing and managing various thyroid pathologies.

Purpose of the Study:

  • To investigate differential DEHAL1 expression across various thyroid pathologies.
  • To evaluate DEHAL1 as a potential biomarker for thyroid cell differentiation.

Main Methods:

  • Real-time PCR was used to quantify DEHAL1 and DEHAL1B mRNA in 105 thyroid specimens.
  • Immunohistochemistry assessed DEHAL1 protein expression in 163 thyroid samples.
  • Specimens included normal thyroids, toxic nodules, Graves' disease, cold nodules, and various thyroid cancers.

Main Results:

  • Highest DEHAL1 mRNA levels were observed in Graves' disease thyroids.
  • Downregulation of DEHAL1 mRNA was noted in papillary and anaplastic thyroid carcinomas.
  • DEHAL1 protein was overexpressed in toxic nodules and Graves' disease, with apical staining; differentiated cancers showed diffuse cytoplasmic staining, while poorly differentiated cancers had faint or absent expression.

Conclusions:

  • Upregulated DEHAL1 protein and apical localization in toxic conditions correlate with increased thyroid hormone turnover.
  • Altered or reduced DEHAL1 expression in thyroid cancers suggests a loss of function during dedifferentiation.
  • DEHAL1 expression patterns may serve as an indicator of thyroid cell differentiation and malignancy.
Abstract

More Related Videos

An Ex vivo Culture System to Study Thyroid Development08:33

An Ex vivo Culture System to Study Thyroid Development

Published on: June 6, 2014

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...